'The Immune Bomb' – Investigating Immunotherapy Combinations for Use in Ultrasound Triggered Liposomes in Targeted Treatment of Cancer

During my project in the Institute of Biomedical Engineering, Oxford I worked on developing liposomes containing immune modulators including the immune checkpoint inhibitor monoclonal antibodies anti-OX40 and anti PD-L1.

Like Comment
Page of

Morgan Elsmore

Associate, Boston Consulting Group (BCG)

No comments yet.